Browse > Article
http://dx.doi.org/10.4062/biomolther.2017.113

Molecular and Functional Characterization of Choline Transporter-Like Proteins in Esophageal Cancer Cells and Potential Therapeutic Targets  

Nagashima, Fumiaki (Department of Anesthesiology, Tokyo Medical University)
Nishiyama, Ryohta (Department of Anesthesiology, Tokyo Medical University)
Iwao, Beniko (Department of Psychiatry, Tokyo Medical University)
Kawai, Yuiko (Institute of Medical Science, Tokyo Medical University)
Ishii, Chikanao (Institute of Medical Science, Tokyo Medical University)
Yamanaka, Tsuyoshi (Department of Molecular Preventive Medicine, Tokyo Medical University)
Uchino, Hiroyuki (Department of Anesthesiology, Tokyo Medical University)
Inazu, Masato (Institute of Medical Science, Tokyo Medical University)
Publication Information
Biomolecules & Therapeutics / v.26, no.4, 2018 , pp. 399-408 More about this Journal
Abstract
In this study, we examined the molecular and functional characterization of choline uptake in the human esophageal cancer cells. In addition, we examined the influence of various drugs on the transport of [$^3H$]choline, and explored the possible correlation between the inhibition of choline uptake and apoptotic cell death. We found that both choline transporter-like protein 1 (CTL1) and CTL2 mRNAs and proteins were highly expressed in esophageal cancer cell lines (KYSE series). CTL1 and CTL2 were located in the plasma membrane and mitochondria, respectively. Choline uptake was saturable and mediated by a single transport system, which is both $Na^+$-independent and pH-dependent. Choline uptake and cell viability were inhibited by various cationic drugs. Furthermore, a correlation analysis of the potencies of 47 drugs for the inhibition of choline uptake and cell viability showed a strong correlation. Choline uptake inhibitors and choline deficiency each inhibited cell viability and increased caspase-3/7 activity. We conclude that extracellular choline is mainly transported via a CTL1. The functional inhibition of CTL1 by cationic drugs could promote apoptotic cell death. Furthermore, CTL2 may be involved in choline uptake in mitochondria, which is the rate-limiting step in S-adenosylmethionine (SAM) synthesis and DNA methylation. Identification of this CTL1- and CTL2-mediated choline transport system provides a potential new target for esophageal cancer therapy.
Keywords
Choline; Transporter; Esophageal cancer; Apoptotic cell death; Caspase-3/7;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Tian, M., Zhang, H., Oriuchi, T., Higuchi, T. and Endo, K. (2004) Comparison of $^{11}C$-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur. J. Nucl. Med. Mol. Imaging 31, 1064-1072.
2 Uchida, Y., Inazu, M., Takeda, H., Yamada, T., Tajima, H. and Matsumiya, T. (2009) Expression and functional characterization of choline transporter in human keratinocytes. J. Pharmacol. Sci. 109, 102-109.   DOI
3 Wang, T., Li, J., Chen, F., Zhao, Y., He, X., Wan, D. and Gu, J. (2007) Choline transporters in human lung adenocarcinoma: expression and functional implications. Acta Biochim. Biophys. Sin. (Shanghai) 39, 668-674.   DOI
4 Xu, X. C. (2009) Risk factors and gene expression in esophageal cancer. Methods Mol. Biol. 471, 335-360.
5 Yabuki, M., Inazu, M., Yamada, T., Tajima, H. and Matsumiya, T. (2009) Molecular and functional characterization of choline transporter in rat renal tubule epithelial NRK-52E cells. Arch. Biochem. Biophys. 485, 88-96.   DOI
6 Yamada, T., Inazu, M., Tajima, H. and Matsumiya, T. (2011) Functional expression of choline transporter-like protein 1 (CTL1) in human neuroblastoma cells and its link to acetylcholine synthesis. Neurochem. Int. 58, 354-365.   DOI
7 Yara, M., Iwao, B., Hara, N., Yamanaka, T., Uchino, H. and Inazu, M. (2015) Molecular and functional characterization of choline transporter in the human trophoblastic cell line JEG-3 cells. Placenta 36, 631-637.   DOI
8 Yen, C. L., Mar, M. H. and Zeisel, S. H. (1999) Choline deficiency-induced apoptosis in PC12 cells is associated with diminished membrane phosphatidylcholine and sphingomyelin, accumulation of ceramide and diacylglycerol, and activation of a caspase. FASEB J. 13, 135-142.   DOI
9 Zhang, Y. (2013) Epidemiology of esophageal cancer. World J. Gastroenterol. 19, 5598-5606.   DOI
10 Bertagna, F., Bertoli, M., Treglia, G., Manenti, S., Salemme, M. and Giubbini, R. (2014) Incidental $^{11}C$-Choline PET/CT uptake due to Esophageal carcinoma in a patient studied for prostate cancer. Clin. Nucl. Med. 39, e442-e444.   DOI
11 Eliyahu, G., Kreizman, T. and Degani, H. (2007) Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int. J. Cancer 120, 1721-1730.   DOI
12 Glunde, K., Jiang, L., Moestue, S. A. and Gribbestad, I. S. (2011) MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer. NMR Biomed. 24, 673-690.   DOI
13 Fujita, T., Shimada, A., Okada, N. and Yamamoto, A. (2006) Functional characterization of Na+-independent choline transport in primary cultures of neurons from mouse cerebral cortex. Neurosci. Lett. 393, 216-221.   DOI
14 Garcia, J. R., Ponce, A., Canales, M., Ayuso, J., Moragas, M. and Soler, M. (2014) Detection of second tumors in $^{11}C$-choline PET/CT studies performed due to biochemical recurrence of prostate cancer. Rev. Esp. Med. Nucl. Imagen Mol. 33, 28-31.
15 Gllies, R. J. and Morse, D. L. (2005) In vivo magnetic resonance spectroscopy in cancer. Annu. Rev. Biomed. Eng. 7, 287-326.   DOI
16 Glunde, K., Jacobs, M. A. and Bhujwalla, Z. M. (2006) Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev. Mol. Diagn. 6, 821-829.   DOI
17 Inazu, M. (2014) Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy. Biopharm. Drug Dispos. 35, 431-449.   DOI
18 Inazu, M., Takeda, H. and Matsumiya, T. (2005) Molecular and functional characterization of an $Na^+$-independent choline transporter in rat astrocytes. J. Neurochem. 94, 1427-1437.   DOI
19 Iwao, B., Yara, M., Hara, N., Kawai, Y., Yamanaka, T., Nishihara, H., Inoue, T. and Inazu, M. (2016) Functional expression of choline transporter like-protein 1 (CTL1) and CTL2 in human brain microvascular endothelial cells. Neurochem. Int. 93, 40-50.   DOI
20 Inazu, M., Yamada, T., Kubota, N. and Yamanaka, T. (2013) Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: a target molecule for lung cancer therapy. Pharmacol. Res. 76, 119-131.   DOI
21 Kaelin, W. G., Jr. and McKnight, S. L. (2013) Influence of metabolism on epigenetics and disease. Cell 153, 56-69.   DOI
22 Kaplan, C. P., Porter, R. K. and Brand, M. D. (1993) The choline transporter is the major site of control of choline oxidation in isolated rat liver mitochondria. FEBS Lett. 321, 24-26.   DOI
23 Kommareddi, P. K., Nair, T. S., Thang, L. V., Galano, M. N., Babu, E., Ganapathy, V., Kanazawa, T., McHugh, J. B. and Carey, T. E. (2010) Isoforms, expression, glycosylation, and tissue distribution of CTL2/SLC44A2. Protein J. 29, 417-426.   DOI
24 Kouji, H., Inazu, M., Yamada, T., Tajima, H., Aoki, T. and Matsumiya, T. (2009) Molecular and functional characterization of choline transporter in human colon carcinoma HT-29 cells. Arch. Biochem. Biophys. 483, 90-98.   DOI
25 Liu, D., Hutchinson, O. C., Osman, S., Price, P., Workman, P. and Aboagye, E. O. (2002) Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin. Br. J. Cancer 87, 783-789.   DOI
26 O'Donoghue, N., Sweeney, T., Donagh, R., Clarke, K. J. and Porter, R. K. (2009) Control of choline oxidation in rat kidney mitochondria. Biochim. Biophys. Acta 1787, 1135-1139.   DOI
27 Michel, V. and Bakovic, M. (2012) The ubiquitous choline transporter SLC44A1. Cent. Nerv. Syst. Agents Med. Chem. 12, 70-81.   DOI
28 Ackerstaff, E., Glunde, K. and Bhujwalla, Z. M. (2003) Choline phospholipid metabolism: a target in cancer cells? J. Cell. Biochem. 90, 525-533.   DOI
29 Nair, T. S., Kozma, K. E., Hoefling, N. L., Kommareddi, P. K., Ueda, Y., Gong, T. W., Lomax, M. I., Lansford, C. D., Telian, S. A., Satar, B., Arts, H. A., El-Kashlan, H. K., Berryhill, W. E., Raphael, Y. and Carey, T. E. (2004) Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing loss. J. Neurosci. 24, 1772-1779.   DOI
30 Nishiyama, R., Nagashima, F., Iwao, B., Kawai, Y., Inoue, K., Midori, A., Yamanaka, T., Uchino, H. and Inazu, M. (2016) Identification and functional analysis of choline transporter in tongue cancer: A novel molecular target for tongue cancer therapy. J. Pharmacol. Sci. 131, 101-109.   DOI
31 Ossani, G., Dalghi, M. and Repetto, M. (2007) Oxidative damage lipid peroxidation in the kidney of choline-deficient rats. Front. Biosci. 12, 1174-1183.   DOI
32 Porter, R. K., Scott, J. M. and Brand, M. D. (1992) Choline transport into rat liver mitochondria. Characterization and kinetics of a specific transporter. J. Biol. Chem. 267, 14637-14646.
33 Shimada, Y., Imamura, M., Wagata, T., Yamaguchi, N. and Tobe, T. (1992) Characterization of 21 newly established esophageal cancer cell lines. Cancer 69, 277-284.   DOI
34 Tachimori, Y., Ozawa, S., Numasaki, H., Fujishiro, M., Matsubara, H., Oyama, T., Shinoda, M., Toh, Y., Udagawa, H. and Uno, T. (2016) Comprehensive registry of esophageal cancer in Japan, 2009. Esophagus 13, 110-137.   DOI
35 Taguchi, C., Inazu, M., Saiki, I., Yara, M., Hara, N., Yamanaka, T. and Uchino, H. (2014) Functional analysis of [methyl-$^3H$]choline uptake in glioblastoma cells: influence of anti-cancer and central nervous system drugs. Biochemical. Pharmacol. 88, 303-312.   DOI
36 Albright, C. D., Liu, R., Bethea, T. C., Da Costa, K. A., Salganik, R. I. and Zeisel, S. H. (1996) Choline deficiency induces apoptosis in SV40-immortalized CWSV-1 rat hepatocytes in culture. FASEB J. 10, 510-516.   DOI
37 Balassiano, K., Lima, S., Jenab, M., Overvad, K., Tjonneland, A., Boutron-Ruault, M. C., Clavel-Chapelon, F., Canzian, F., Kaaks, R., Boeing, H., Meidtner, K., Trichopoulou, A., Laglou, P., Vineis, P., Panico, S., Palli, D., Grioni, S., Tumino, R., Lund, E., Buenode-Mesquita, H. B., Numans, M. E., Peeters, P. H., Ramon Quiros, J., Sanchez, M. J., Navarro, C., Ardanaz, E., Dorronsoro, M., Hallmans, G., Stenling, R., Ehrnstrom, R., Regner, S., Allen, N. E., Travis, R. C., Khaw, K. T., Offerhaus, G. J., Sala, N., Riboli, E., Hainaut, P., Scoazec, J. Y., Sylla, B. S., Gonzalez, C. A. and Herceg, Z. (2011) Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Cancer Lett. 311, 85-95.   DOI